Cargando…
Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare setting
OBJECTIVES: Biological products have contributed to extraordinary advances in disease treatments over the last decade. However, the cost-saving potential of imitator products, so-called biosimilars, is still under-researched in Switzerland. This study aims to assess biosimilars’ prescriptions at tre...
Autores principales: | Wirth, Kevin, Boes, Stefan, Näpflin, Markus, Huber, Carola, Blozik, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668177/ https://www.ncbi.nlm.nih.gov/pubmed/37989386 http://dx.doi.org/10.1136/bmjopen-2023-077454 |
Ejemplares similares
-
Opioid prescriptions after knee replacement: a retrospective study of pathways and prognostic factors in the Swiss healthcare setting
por: Wirth, Kevin, et al.
Publicado: (2023) -
Continuity of care and treatment intensity at the end of life in Swiss cancer patients
por: Bähler, Caroline, et al.
Publicado: (2023) -
Does hospital volume affect outcomes after abdominal cancer surgery: an analysis of Swiss health insurance claims data
por: Wirth, Kevin, et al.
Publicado: (2022) -
Evidence-based quality indicators for primary healthcare in association with the risk of hospitalisation: a population-based cohort study in Switzerland
por: Huber, Carola A, et al.
Publicado: (2020) -
Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes
por: Landolt, Salome, et al.
Publicado: (2021)